Morgan Stanley’s Kiora Pharmaceuticals KPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.7K | Hold |
1,408
| – | – | ﹤0.01% | 7280 |
|
|
2026
Q1 | $2.72K | Buy |
+1,408
| New | +$2.97K | ﹤0.01% | 7272 |
|
|
2025
Q2 | – | Sell |
-700
| Closed | -$2.11K | – | 8199 |
|
|
2025
Q1 | $2.11K | Buy |
+700
| New | +$2.43K | ﹤0.01% | 7168 |
|
|
2024
Q3 | – | Sell |
-1
| Closed | -$4 | – | 7989 |
|
|
2024
Q2 | $4 | Hold |
1
| – | – | ﹤0.01% | 7812 |
|
|
2024
Q1 | $6 | Hold |
1
| – | – | ﹤0.01% | 7786 |
|
|
2023
Q4 | $4 | Hold |
1
| – | – | ﹤0.01% | 7787 |
|
|
2023
Q3 | $5 | Hold |
1
| – | – | ﹤0.01% | 7576 |
|
|
2023
Q2 | $5 | Hold |
1
| – | – | ﹤0.01% | 7623 |
|
|
2023
Q1 | $27 | Sell |
1
-12
| -92% | -$448 | ﹤0.01% | 7628 |
|
|
2022
Q4 | $397 | Sell |
13
-251
| -95% | -$11.6K | ﹤0.01% | 7582 |
|
|
2022
Q3 | $15K | Buy |
264
+263
| +26,300% | +$20.5K | ﹤0.01% | 6922 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 7894 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 8041 |
|
|
2021
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 7874 |
|
|
2021
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 7784 |
|
|
2021
Q2 | $2K | Hold |
1
| – | – | ﹤0.01% | 7528 |
|
|
2021
Q1 | $2K | Hold |
1
| – | – | ﹤0.01% | 7271 |
|
|
2020
Q4 | $2K | Hold |
1
| – | – | ﹤0.01% | 6894 |
|
|
2020
Q3 | $2K | Hold |
1
| – | – | ﹤0.01% | 6573 |
|
|
2020
Q2 | $2K | Hold |
1
| – | – | ﹤0.01% | 6450 |
|
|
2020
Q1 | $2K | Hold |
1
| – | – | ﹤0.01% | 6389 |
|
|
2019
Q4 | $3K | Hold |
1
| – | – | ﹤0.01% | 6461 |
|
|
2019
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 6553 |
|
|
2019
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 6546 |
|
|
2019
Q1 | $2K | Hold |
1
| – | – | ﹤0.01% | 6455 |
|
|
2018
Q4 | $2K | Hold |
1
| – | – | ﹤0.01% | 6419 |
|
|
2018
Q3 | $2K | Hold |
1
| – | – | ﹤0.01% | 6575 |
|
|
2018
Q2 | $3K | Hold |
1
| – | – | ﹤0.01% | 6508 |
|
|
2018
Q1 | $3K | Buy |
+1
| New | +$4.32K | ﹤0.01% | 6457 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6488 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6448 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6506 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6423 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6440 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6426 |
|
|
2016
Q2 | – | Sell |
-1
| Closed | -$17.4K | – | 6301 |
|
|
2016
Q1 | $16K | Hold |
1
| – | – | ﹤0.01% | 5998 |
|
|
2015
Q4 | $14K | Buy |
+1
| New | +$16.1K | ﹤0.01% | 6142 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 6448 |
|
Other funds holding KPRX
PA
ACM
HF
SRL
Morgan Stanley's KPRX Position: Q2 2026 in Review
Morgan Stanley held its Kiora Pharmaceuticals (KPRX) position steady in Q2 2026 at 1,408 shares worth $3.7K. The position accounts for ﹤0.01% of the portfolio, ranked #7280.
Morgan Stanley first reported a position in KPRX in Q4 2015 and has held it in 31 quarters since. The position peaked at $16K in Q1 2016. 22 funds tracked by Wall St. Rank hold KPRX as of Q2 2026.
- Morgan Stanley held 1,408 shares of Kiora Pharmaceuticals worth $3.7K as of Q2 2026.
- Morgan Stanley left its Kiora Pharmaceuticals share count unchanged in Q2 2026.
- Kiora Pharmaceuticals made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7280 holding.
- Morgan Stanley first reported a position in Kiora Pharmaceuticals in Q4 2015 and has held it in 31 quarters since.
- Morgan Stanley's Kiora Pharmaceuticals position peaked at $16K in Q1 2016.
- 22 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.